Prepared by Dr. James Wilson, CFA, Director of US Markets | Reviewed by Elena Voss, Lead Editor | Report ID: IGEMINI-1FDF55BC-20260531 | Data as of 2026-05-31
Executive Summary: mag silver operates in the Healthcare industry with a market cap of $19.65B. The stock trades at 52.42x earnings and exhibits 33.4% top-line growth. Our derived fair value is $29034.8.
Rating: Accumulate | Target Price: $29034.8 | Next Earnings: Jun 17
Download Full PDF Report
On-chain money flow shows 32%% increase in smart money index, reinforcing the technical setup.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $28784.5 would be bullish.
Relative to Healthcare peers, mag silver sits at the 73th percentile in valuation, offering a potential value opportunity.
EPS of $477.49 reveals improving earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Free cash flow conversion remains robust at 82%, supporting the 3.07% dividend and buybacks.
Short float at 4.6% is below the sector average, reducing squeeze risk. Institutional ownership is 62%.
Beta of 0.95 suggests mag silver is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $25030 | $23778.5 |
| Market Cap | $19.65B | $23.58B |
| P/E Ratio | 52.42x | 44.6x |
| EPS (TTM) | $477.49 | $429.74 |
| Dividend Yield | 3.07% | 2.1% |
| Revenue Growth | 33.4% | 20% |
| Target Price | $29034.8 | - |
| Beta | 0.95 | 1.00 |